Alan Rapoport

8PUBLICATIONS
18CO-AUTHORS
Regenerative medicine (incl. stem cells)Traditional Chinese medicine and treatmentsMedical molecular engineering of nucleic acids and proteinsPharmaceutical delivery technologiesNaturopathy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 17, 2025
Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon.

Stephanie J Nahas, Marius Birlea, Alit Stark-Inbar

|Sep 12, 2025
Optimising combined treatment for migraine and temporomandibular disorders (TMDs).

Marcela Romero-Reyes, Simon Akerman, Alan M Rapoport

|Oct 07, 2024
Continuing evolution of migraine-specific therapies - targeting migraine with precision and persistence.

Dimos D Mitsikostas, Alan Rapoport

|Oct 07, 2024
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study.

Stewart J Tepper, Detlef Albrecht, Jessica Ailani

|Jul 12, 2023
The 5-HT1F receptor as the target of ditans in migraine - from bench to bedside.

Dimos D Mitsikostas, Christian Waeber, Margarita Sanchez-Del-Rio

|Apr 12, 2023
Device profile of Nerivio for the acute and preventive treatment of episodic or chronic migraine in patients 12 years and older.

Mahsa Babaei, Alan M Rapoport

Pageof 2

Frequent Collaborators

2 joint publications

Dimos D Mitsikostas

1 joint publications

Christina Sun-Edelstein

1 joint publications

Anan Srikiatkhachorn

1 joint publications

Richard B Lipton